Abstract
The report covers forecast and analysis for the Gallbladder Treatment market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Billion). The study includes drivers and restraints for the Gallbladder Treatment market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the Gallbladder Treatment market on a global level. In order to give the users of this report a comprehensive view on the Gallbladder Treatment market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein disease indications, diagnosis, treatment, end users, and regional segments are benchmarked based on their market size, growth rate and general attractiveness.
The gall bladder is a tiny pear-shaped situated below the liver. Its primary role is to hold the bile produced by liver and allow transfer of it along through a duct that discharges into the small intestine. Gall bladder disorders affect a large number of people around the world. Gall bladder disorders impact a significant number of people around the globe. Gall bladder and associated biliary diseases arose in approximately 104 million people (1.6 percent) in 2016 and culminated in 106,000 deaths. Growing geriatric population, growing the prevalence rate of various gallbladder diseases, and developing and embracing innovative diagnostic treatment options are the major drivers for market development. In addition, growing awareness of the diseases, increasing healthcare spending and rising demand from Asia's emerging markets have fuelled market growth. Nevertheless, discomfort and health risks during operation and the symptomless nature of gall stones can delay market growth.
The study provides a decisive view on the Gallbladder Treatment market by segmenting the market based on disease indications, diagnosis, treatment, end users, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2020 to 2026. Based on disease indications, the market is segmented into gallstones, cholecystitis and biliary colic, cholelithiasis and choledocholithiasis, gallbladder polyps, gall bladder cancer.
Based on diagnosis, the market is segmented into ultrasound, blood tests, computerized tomography (CT), cholangiography and hepatobiliary scintigraphy.. Based on treatment, the market is segmented into surgery, and drugs. Based on end users, the market is segmented into hospitals & gynecology clinics, Academic & Research Centers. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Geographically speaking, North America dominated the gallbladder treatment market. Large gallbladder treatment patient pool, availability of developed infrastructure, growing awareness and presence of key players has led to increased demand for gallbladder treatment.
Growing geriatric population, growing the prevalence rate of various gallbladder diseases, and developing and embracing innovative diagnostic treatment options is accelerating the growth of the demand for gallbladder treatment. In addition, the increase in lifestyle spending as well as growing people's awareness drives the growth of the market for gallbladder treatment. However, discomfort and health risks during operation and the symptomless nature of gall stones may hamper the growth of the market for gallbladder treatment.
Key players within global Gallbladder Treatment market include Boston Scientific Corporation, Intuitive Surgical, C. R. Bard, Inc., Dornier MedTech, Koninklijke Philips N.V., B. Braun Melsungen AG, Sanofi and others others.
The report segments global Gallbladder Treatment market as follows:
Global Gallbladder Treatment Market: Disease Indications Segment Analysis
Gallstones
Cholecystitis And Biliary Colic
Cholelithiasis And Choledocholithiasis
Gallbladder Polyps
Gall Bladder Cancer
Global Gallbladder Treatment Market: Diagnosis Segment Analysis
Ultrasound
Blood Tests
Computerized Tomography (CT)
Cholangiography
Hepatobiliary Scintigraphy
Global Gallbladder Treatment Market: By Treatment Segment Analysis
Surgery
Drugs
Global Gallbladder Treatment Market: End Users Segment Analysis
Hospitals & Gynecology Clinics
Academic & Research Centers
Global Gallbladder Treatment Market: Regional Segment Analysis
North America
The U.S.
Canada
Europe
France
The UK
Spain
Germany
Italy
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Southeast Asia
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa